100mg Xpreza Azacitidine Injection

100mg Xpreza Azacitidine Injection Specification

Origin of Medicine
India

Brand Name
Xpreza

Indication
Treatment of myelodysplastic syndromes

Salt Composition
Azacitidine 100mg

Life Span
2 years (from date of manufacture)

Dosage Form
Powder for injection

Packaging Type
Vial

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type

Ingredients
Azacitidine

Physical Form
Injection

Function

Recommended For
Adults with myelodysplastic syndromes

Dosage
100 mg per vial

Dosage Guidelines
As directed by physician

Suitable For
Adults

Storage Instructions
Store below 25C, protect from light

Route of Administration
Subcutaneous or intravenous injection

Marketed By
Natco Pharma Limited

Shelf Life After Reconstitution
Use immediately or within 1 hour at 2C - 8C

Regulatory Approval
WHO-GMP Certified, DCGI Approved

Therapeutic Class
Antineoplastic Agent

Prescription/Non-Prescription
Prescription

Appearance
White to off-white lyophilized powder

Reconstitution Solvent
Sterile water for injection

About 100mg Xpreza Azacitidine Injection

Strength	100 mg
Form	Injection
Brand	Xpreza
Manufacturer	Natco
Packaging Type	Vial
Prescription/Non prescription	Prescription
Packaging Size	100 ml

Xpreza Injection is used to treat myelodysplastic syndrome, a group of conditions in which the bone marrow produces blood cells that are abnormal in structure and function, and does not produce enough healthy blood cells.

Reliable Therapy for Myelodysplastic Syndromes

Xpreza Azacitidine Injection delivers targeted and clinically-proven chemotherapy for adults diagnosed with myelodysplastic syndromes. Its formulation ensures effective management of abnormal blood cell production, supporting improved patient outcomes in this complex condition.

Quality-Assured Manufacturing

Manufactured and marketed in India by Natco Pharma Limited, Xpreza is both WHO-GMP certified and DCGI approved. This guarantees stringent quality standards, offering peace of mind for healthcare providers and patients alike.

Simple Preparation and Administration

Each vial of Xpreza must be reconstituted with sterile water for injection, as provided. The freshly prepared solution should be used immediately or stored for up to one hour at 2C-8C, delivering flexibility and safety during administration, either subcutaneously or intravenously.

FAQ's of 100mg Xpreza Azacitidine Injection:

Q: How should Xpreza Azacitidine Injection be reconstituted and administered?

A: Xpreza must be reconstituted with the supplied sterile water for injection. The solution should be prepared freshly before use and administered either subcutaneously or intravenously as directed by a physician.

Q: What is the recommended dosage for Xpreza Azacitidine Injection?

A: The typical dosage is 100mg per vial. The exact dosage regimen and duration depend on your specific condition and will be determined by your healthcare provider.

Q: When should the reconstituted solution be used and how should it be stored?

A: Once reconstituted, the Xpreza solution should be used immediately. If needed, it can be stored at 2C-8C and must be used within one hour to ensure efficacy and safety.

Q: Where should Xpreza Azacitidine Injection be stored before use?

A: Keep the unopened vials stored below 25C and protect them from light. Follow all storage guidelines to preserve the quality and effectiveness of the medication.

Q: What are the benefits of using Xpreza for myelodysplastic syndromes?

A: Xpreza helps manage abnormal blood cell production in adults with myelodysplastic syndromes, potentially delaying disease progression and improving quality of life.

Q: Who can be prescribed Xpreza Azacitidine Injection?

A: Xpreza is indicated for adult patients diagnosed with myelodysplastic syndromes and is available only by prescription. Suitability and use must be assessed and supervised by a healthcare professional.